e-learning
resources
ERJ
2007
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Activation of E-prostanoid4 and E-prostanoid2 receptors inhibits TNF-α release from human alveolar macrophages
Ratcliffe M. J., Walding A., Shelton P. A., Flaherty A., Dougall I. G.
Source:
Eur Respir J 2007; 29: 986-994
Journal Issue:
May
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ratcliffe M. J., Walding A., Shelton P. A., Flaherty A., Dougall I. G.. Activation of E-prostanoid4 and E-prostanoid2 receptors inhibits TNF-α release from human alveolar macrophages. Eur Respir J 2007; 29: 986-994
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
N3 hilar sampling decision in the staging of mediastinal lung cancer
Asbestosis
Related content which might interest you:
Oxidative burst in lipopolysaccharide-activated human alveolar macrophages is inhibited by interleukin-9
Source: Eur Respir J 2002; 20: 1198-1205
Year: 2002
Prostaglandin-E
2
mediated inhibition of TNFα release from human alveolar macrophages
Source: Eur Respir J 2005; 26: Suppl. 49, 223s
Year: 2005
Protease activated receptor 2 (PAR2) antagonism reduces pro-inflammatory cytokine production in bronchial epithelial cells
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020
Activation of human alveolar macrophages via P2 receptors: influcence on intracellular Ca
2+
and cytokine secretion
Source: Annual Congress 2008 - Understanding airway inflammation
Year: 2008
Prostaglandin E2 inhibits NLRP3 inflammasome activation through EP4 receptor and intracellular cAMP in human macrophages
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Protein S inhibits the secretion of inflammatory cytokines from alveolar epithelial cells
Source: Annual Congress 2008 - Structural remodelling in COPD
Year: 2008
CCL5 (RANTES) inhibits TGF-β1-induced collagen production in human bronchial epithelial cells by action of Smad protein
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009
Histamine-stimulated monocytes release microparticles that upregulate IL-8 synthesis by human alveolar epithelial cells
Source: Eur Respir J 2006; 28: Suppl. 50, 228s
Year: 2006
Human neutrophil peptides stimulate the production of TNF alpha by alveolar macrophages from patients with sarcoidosis
Source: Annual Congress 2007 - Inflammatory cell biology
Year: 2007
Eosinophil cationic protein stimulates TGF-β
1
release by human lung fibroblasts
Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma
Year: 2005
Late-breaking abstract: Activation of the macrophage inflammasome by TLR3 ligation potentiates release of IL-8 and IP-10 from alveolar type II epithelial cells via a paracrine cytokine network
Source: Annual Congress 2011 - Epithelial cells: role in health and disease
Year: 2011
Histamine modulates interleukin 10 secretion from human alveolar macrophages
via
H2 and H4 histamine receptors
Source: Eur Respir J 2007; 30: Suppl. 51, 690s
Year: 2007
Glucocorticoids induce a shift in chemokine profile in LPS-stimulated human alveolar macrophages
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018
Role of nicotinic receptors in the regulation of cytokines production by human lung macrophages
Source: Annual Congress 2012 - Mechanistic studies in airway cell biology
Year: 2012
Curcumin induces glutathione biosynthesis and inhibits NF-κB activation and interleukin-8 release in alveolar epithelial cells
Source: Eur Respir J 2004; 24: Suppl. 48, 29s
Year: 2004
Liver-X-receptor agonists, but not dexamethasone, inhibit leukotriene production from human white blood cells pretreated with GM-CSF and activated with fMLP
Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence
Year: 2007
Inhibition of LPS-induced cytokine/chemokine production from human lung macrophages by roflumilast is enabled by autocrine PGE
2
Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics
Year: 2010
Inhibition of IRAK4 suppresses chemokine release from human bronchial epithelial cells
Source: Annual Congress 2013 –Molecular biology: state-of-the-art 2013
Year: 2013
IgA inhibits LPS-induced IL-10 in human alveolar macrophages (HAM)
Source: Eur Respir J 2005; 26: Suppl. 49, 585s
Year: 2005
Stimulation of P2 purinergic receptors induces the release of eosinophil cationic protein and interleukin-8 from human eosinophils
Source: Eur Respir J 2003; 22: Suppl. 45, 548s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept